Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014

15th Annual Drug Discovery Leaders Summit

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland

Bookmark and Share

Attend Europe’s leading networking and discussion platform for drug discovery professionals.  

Meet 250 senior-level delegates from global pharmaceutical organisations, leading biotechs and esteemed academic institutions.

Hear 60 expert speakers discuss the pressing challenges in medicinal chemistry, compound screening, target-based discovery and innovation access.

Discuss the viability of the latest discovery trends, including phenotypic screening, epigenetic drug discovery, stem cell technology and nanoengineering.

Tailor your congress experience – attend any sessions from the following six streams:

- R&D Models For The Future

- Screening & Assays: Enabling Technologies

- Target Based Discovery

- Supporting Innovation: Data & Information Management

- Discovery Chemistry: Latest Case Studies

- Drug Design: Novel Approaches

The Summit is co-located with the 6th Annual Drug Development Congress - an executive level event focusing on predictive science and translational medicine.

The Drug Discovery Summit is Europe’s leading networking and discussion platform for pharmaceutical professionals. Attending this long-established event gives delegates the opportunity to:

Hear from and meet with the people shaping the pharmaceutical landscape. Previous attendees include: Vice President New Frontier Science Europe, Takeda; Vice President and Venture Leader, Janssen R&D; Vice President & Global Head, Reagents & Assay Development, AstraZeneca.

Discuss the latest discovery innovations, including 3D cell based assays, advances in nanoengineering and iPSCs for compound screening.

Discover collaborative solutions to discovery challenges. This summit brings together a host of experts to compare methods for utilising new screening technology, validating novel drug targets, improving lead optimisation and making better use of discovery data.

Enjoy unparalleled networking opportunities. The two-day congress format combines dedicated networking breaks, pre-organised 1-2-1 meetings and our popular drinks reception. The exhibition hall and poster presentation spaces offer a relaxed and professional environment for discussion.

Tailor the congress experience.  The six stream agenda offers industry updates for those working in discovery technology, target-based discovery, discovery information, discovery chemistry, drug design, research strategy and open innovation.

Contact Danielle Dalby to download the agenda and for attendance information on or call +44 (0)1865 248455

Further information
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Structure of Primary Cannabinoid Receptor is Revealed
The findings provide key insights into how natural and synthetic cannabinoids including tetrahydrocannabinol —a primary chemical in marijuana—bind at the CB1 receptor to produce their effects.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
NIH Study Determines Key Differences between Allergic and Non-Allergic Dust Mite Proteins
Researchers at NIH have uncovered factors that lead to the development of dust mite allergy and assist in the design of better allergy therapies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos